Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
In addition, our multilingual team is happy to assist customers with product inquiries, orders, and shipping questions across language barriers
The treatment process may vary depending on the symptoms, such as brain fog, numbness, exhaustion, or a slow metabolism
Individuals with B12 deficiencies often experience a reduction in serotonin levels, which decreases mood and energy
Immediate Energy Boost: Many people report a noticeable improvement in energy levels soon after their injection